Inhibition of CXCR4/CXCL12 signaling: a translational perspective for Alzheimer's disease treatment
Neural Regen Res
.
2022 Jan;17(1):108-109.
doi: 10.4103/1673-5374.314303.
Authors
Yuval Gavriel
1
,
Inna Rabinovich-Nikitin
1
,
Beka Solomon
1
Affiliation
1
The Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
PMID:
34100443
PMCID:
PMC8451578
DOI:
10.4103/1673-5374.314303
No abstract available